HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,151,497 | -28.8% | 80,132 | -5.7% | 0.00% | – |
| Q2 2023 | $1,617,410 | +66.1% | 84,948 | +84.5% | 0.00% | – |
| Q1 2023 | $973,995 | -35.9% | 46,030 | -55.3% | 0.00% | – |
| Q4 2022 | $1,518,893 | +0.7% | 102,906 | -17.7% | 0.00% | -100.0% |
| Q3 2022 | $1,509,000 | +65.8% | 124,962 | 0.0% | 0.00% | – |
| Q2 2022 | $910,000 | +6.7% | 124,962 | 0.0% | 0.00% | – |
| Q1 2022 | $853,000 | -21.0% | 124,962 | 0.0% | 0.00% | – |
| Q4 2021 | $1,080,000 | -4.9% | 124,962 | 0.0% | 0.00% | – |
| Q3 2021 | $1,136,000 | -2.2% | 124,962 | 0.0% | 0.00% | – |
| Q2 2021 | $1,161,000 | +208.8% | 124,962 | +124.5% | 0.00% | – |
| Q1 2021 | $376,000 | -1.6% | 55,666 | 0.0% | 0.00% | – |
| Q4 2020 | $382,000 | +30.8% | 55,666 | +6.9% | 0.00% | – |
| Q3 2020 | $292,000 | +1.7% | 52,060 | -5.4% | 0.00% | – |
| Q2 2020 | $287,000 | – | 55,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,343,817 | $40,360,000 | 16.67% |
| Invenire Partners, LP | 453,794 | $5,477,293,000 | 8.38% |
| Acuitas Investments, LLC | 337,949 | $4,079,000 | 4.23% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 188,539 | $2,276,000 | 2.47% |
| Ophir Asset Management Pty Ltd | 1,714,464 | $20,694,000 | 1.88% |
| Private Capital Management, LLC | 1,029,356 | $12,424,000 | 1.80% |
| Birchview Capital, LP | 180,000 | $2,173,000 | 1.53% |
| Diametric Capital, LP | 224,090 | $2,705,000 | 1.36% |
| Uniplan Investment Counsel, Inc. | 694,257 | $8,379,000 | 0.64% |
| EAM Investors, LLC | 224,046 | $2,704,000 | 0.59% |